Luis G. Paz-Ares, Hossein Borghaei, Martin Reck, Solange Peters, Roy S. Herbst, Andrzej Kazarnowicz, Aleksandra Szczesna, Erdem Cubukcu, Saadettin Kilickap, Jin-Seok Ahn, Raffaele Califano, Yu-Feng Wei, Minu K. Srivastava, Barzin Y. Nabet, Vilma Graupner, Ya-Chen Lin, George Cai, Graham Brock, Kamalnayan Bhatt, Stephen V. Liu. "Transcriptomic analyses of molecular subsets and correlations with clinical outcomes from the phase 3 IMforte study of lurbinectedin (lurbi) + atezolizumab (atezo) maintenance treatment (Tx) in extensive-stage small-cell lung cancer (ES-SCLC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8014